TOKYO -- Japan's health ministry on Tuesday granted emergency use of a COVID-19 drug developed by Shionogi, making it the country's first domestically produced oral medicine for patients with mild symptoms. The drug is expected to be available for use in early December.

.jpeg?width=700&fit=cover&gravity=faces&dpr=2&quality=medium&source=nar-cms&format=auto&height=394)




